TECHNESCAN SESTAMIBI Australia - English - Department of Health (Therapeutic Goods Administration)

technescan sestamibi

mallinckrodt australia pty ltd - tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate; tetrakis (2-methoxyisobutylisonitrile) copper (i) tetrafluoroborate; tetrakis (2-methoxyisobutyl isonitrile) copper (i) tetrafluoroborate -

CONRAY 280 14/50 Micromol Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

conray 280 14/50 micromol solution for injection

mallinckrodt uk commercial ltd - iotalamate meglumine - solution for injection - 14/50 micromol

Optimark European Union - English - EMA (European Medicines Agency)

optimark

mallinckrodt deutschland gmbh - gadoversetamide - magnetic resonance imaging - contrast media - this medicinal product is for diagnostic use only.optimark is indicated for use with magnetic resonance imaging (mri) of the central nervous system (cns) and liver. it provides contrast enhancement and facilitates visualisation and helps with the characterisation of focal lesions and abnormal structures in the cns and liver in patients with known or highly suspected pathology.

METHADOSE SOLUTION Canada - English - Health Canada

methadose solution

mallinckrodt canada ulc - methadone hydrochloride - solution - 10mg - methadone hydrochloride 10mg - opiate agonists

METHADOSE SOLUTION Canada - English - Health Canada

methadose solution

mallinckrodt canada ulc - methadone hydrochloride - solution - 10mg - methadone hydrochloride 10mg - opiate agonists

OFIRMEV SOLUTION Canada - English - Health Canada

ofirmev solution

mallinckrodt hospital products inc - acetaminophen - solution - 10mg - acetaminophen 10mg - miscellaneous analgesics and antipyretics

RECOTHROM- thrombin topical recombinant United States - English - NLM (National Library of Medicine)

recothrom- thrombin topical recombinant

mallinckrodt hospital products inc. - thrombin alfa (unii: sck81amr7r) (thrombin alfa - unii:sck81amr7r) - thrombin alfa 1000 [iu] in 1 ml - recothrom® thrombin topical (recombinant), is a topical thrombin indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical in adults and pediatric populations greater than or equal to one month of age. recothrom may be used in conjunction with an absorbable gelatin sponge, usp. - do not inject directly into the circulatory system. - do not use for the treatment of massive or brisk arterial bleeding. - do not administer to patients with a history of hypersensitivity to recothrom or any components of recothrom. - do not use in patients with known hypersensitivity to hamster proteins. pregnancy category c animal reproduction studies have not been conducted with recothrom. it is also not known whether recothrom can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. recothrom should be given

neutrospec (Technetium- 99m Tc fanolesomab United States - English - NLM (National Library of Medicine)

neutrospec (technetium- 99m tc fanolesomab

mallinckrodt inc. - fanolesomab (unii: 67etm2384n) (fanolesomab - unii:67etm2384n) - kit - 0.25 mg - neutrospectm [technetium (99m tc) fanolesomab] is indicated for scintigraphic imaging of patients with equivocal signs and symptoms of appendicitis who are five years of age or older. neutrospectm should not be administered to patients who are hypersensitive to any murine proteins or other component of the product. the user should wear waterproof gloves during the entire procedure and while withdrawing the patient dose from the neutrospectm vial. transfer sodium pertechnetate tc 99m injection, usp with an adequately shielded, sterile syringe. adequate shielding should be maintained at all times until the preparation is administered to the patient, disposed of in an approved manner, or allowed to decay to background levels. a shielded, sterile syringe should be used to withdraw and inject the labeled preparation. before reconstituting a vial, it should be inspected for cracks and any indication that the integrity of the vacuum seal has been lost. the material should not be used if integrity of the vacuum